# FDA 483 - Paramesh Banerji Life Sciences, LLC - August 24, 2023

Source: https://www.keypedia.com/records/483/paramesh-banerji-life-sciences-llc/d7ee693b-f6f9-4f5a-b5ad-e6662a4e7ce6

> FDA 483 for Paramesh Banerji Life Sciences, LLC on August 24, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Paramesh Banerji Life Sciences, LLC
- Inspection Date: 2023-08-24
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: Jaranesh Banerji Life Sciences, LLC, a homeopathic drug manufacturer in North Brunswick, NJ, received a Form 483 with seven observations following an FDA inspection. The firm was cited for significant deficiencies across its quality system, including the absence of a quality control unit, lack of written procedures for critical operations, inadequate employee training, and improper storage conditions for drug products. These issues indicate a severe lack of adherence to current good manufacturing practices for drug products.

## Related Documents

- [483 - 2021-09-24](https://www.keypedia.com/records/483/paramesh-banerji-life-sciences-llc/7cbaa98d-1380-4a2b-9699-6d5285c47cdc)

## Related Officers

- [Director of Clinical Training](https://www.keypedia.com/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)

Company: https://www.keypedia.com/companies/paramesh-banerji-life-sciences-llc/8a5dcf24-e253-4116-a968-f9b1a890d15b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248